Health Systems Director

About the role

Develop and execute Private Equity/Top LUGPAs/IDNs/Academic strategic account plans; establish engagement points and actions with appropriate stakeholders to map organizations interests, influence and hierarchy.

Remove barriers within Private Equity/Top LUGPAs/IDNs/Academic/VA/DoD to drive demand.

Facilitates strategic engagement between CG Oncology ELT/senior internal stakeholders and key Private Equity/Top LUGPAs/IDNs/Academic/VA/DoD stakeholders.

Manage large geographies collaborating across National & Regional markets, identifying opportunities and evolving trends across Private Equity/Top LUGPAs/IDNs/Academic/VA/DoD that are consistent with the goals of CG’s key asset launch strategic imperatives.

Align Private Equity/Top LUGPAs/IDNs/Academics with local market strategy & CG leadership.

Bridge alignment between the Health Systems Director and other field-facing roles.

Long Term Strategic Focus; align the goals of the Private Equity/Top LUGPAs/IDNs/Academics with the goals of CG Oncology.

Lead, mobilize, and establish standing pull through and strategic account planning market meetings with all field-facing market stakeholders.

Routinely communicate ongoing success, performance against KBO’s, barriers, and identify new, unique, and profitable business opportunities.

Ensure collaboration and partnership with field leadership, market access, medical, marketing, and operations to ensure best in class launch.

Inform the organization of trends and market insights, risks, opportunities for success, etc.

Thought Leader engagement; develop, inform and influence key opinion leaders (KOLs) champions.

Develop customer specific strategies, account roadmap, segmentation, and account plans for all targeted accounts.

Build and maintain strong long-term customer relationships/partnerships that drive key initiatives related to CG’s growth and success.

Collaborate with field teams (RBDs, UKAMs, FAMs, Market Access, Medical Affairs, etc.) to monitor the market landscape to identify key trends, barriers, and partner with colleagues to mitigate.

Qualifications

• Bachelor’s degree required; MBA or other advanced degree preferred.
• Five (5) years of proven commercial experience within the biopharmaceutical industry or medical device with a minimum of 2-3 years of documented success with IDNs, Large Oncology or Urology Practices, Payers, Key Sites of Care, Healthcare Ecosystems, Private Equity Organizations, Top LUGPAs, and/or national /regional hospital systems.
• Minimum 2 years Uro-Oncology, Urology, Oncology, Precision Medicine, Rare Disease or specialty sales position.
• Deep knowledge and proven success in large hospital sales, IDNs/Academic, large group practices and National/Regional healthcare systems preferred.
• Thorough understanding of hospital ecosystems, large group practices, medical policies, pathway/formulary protocols, and buy and bill process required.
• Strong understanding of health system navigation and decision making.
• Documented access to key stakeholders in targeted accounts preferred.
• Experience and/or proven ability to negotiate with, and sell to, top senior decision makers preferred.
• Demonstrated success in building and maintaining direct relationships with key account decision makers, health systems, IDNs and institutional stakeholders, as well as establishing patient and HCP pull-through support programs.
• Proven ability to define and articulate product value propositions.
• Lead/represent CG at key national and regional meetings, congresses/conferences to drive strongest possible customer engagement across the entire healthcare ecosystem.
• Lead and work cross-functionally at National/Regional/Local GPO meetings to execute and pull-through key account and customer initiatives.